Key points are not available for this paper at this time.
No takes yet. Share an insight, caveat, or question.
Does not support clinical Akt targeting in diabetes; leaves open mechanistic role pending higher-level evidence.
Okon et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: